-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Entero Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2017 to Q1 2024.
- Entero Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $271K, a 24.3% decline year-over-year.
- Entero Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $954K, a 4.87% increase year-over-year.
- Entero Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.04M, a 35.3% increase from 2022.
- Entero Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $769K, a 43.9% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)